Our research projects

Upcoming research projects in our center

Ongoing Pharmacogenetic Research Projects at our Clinic

Eli Lilly
Protocol : D5010C00009
Patients : 55 to 85 years old
Diagnostic : MCI/ Prodromal Alzheimer’s Disease and Alzheimer’s Disease
Agent : Beta secretase inhibitors
Daily oral administration

BIOGEN
Protocol : 221AD302
Patients : 50 to 85 years old
Diagnostic : MCI/ Prodromal Alzheimer’s Disease and Alzheimer’s Disease
Agent : Monoclonal antibodies
Intravenous administration every 4 weeks

TTP
Protocol: TTP488-301
Patients : 50 years old or older
Diagnostic : Alzheimer’s Disease
Agent : Antagonist at the Receptor for Advanced Glycation End products (RAGE)
Daily oral administration

MERCK
Protocol: MK-8931-019
Patients: 50 to 85 years old
Diagnostic: MCI / Prodromal Alzheimer’s Disease
Agent: Beta amyloïd cleaving enzyme inhibitor
Daily oral administration

BAN
Protocol: BAN2401-G000-201
Patients: 50 to 90 years old
Diagnostic: MCI / Prodromal Alzheimer’s Disease
Agent: Anti Amyloid Beta monoclonal antibody
Bi weekly intravenous administration

Non-Pharmacological Project

MoCA-ACE

Are you in good health ? We need your help.
Participate in the validation of a new memory test!

This is about a study directed by Dr Nasreddine neurologist, to create standards for a memory test which will helps health professionals detect early memory disorders associated with different illnesses, such as Alzheimer, Parkinson, multiple sclerosis, head traumas, etc.

We are searching for people with the following criterias:

– Between ages at 18 and 100;
– First language: French;
– In good health;